Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Thoughts on prior art...

RE: Thoughts on prior art...

posted on Apr 11, 2006 05:30AM
J3 have to consider exactly their position and real chances to go on trial. Sure, they can extend ongoing things and avoid payments. But at the end, they risk to lose possible given discount from PTSC/TPL and furthermore they risk to get to be sentenced to a big big amount of money.

Let Pohl/Lecrone do their work, be patient and wait till next company settles. Maybe it sets the ball rolling!

We`ll see!

S402005

Share
New Message
Please login to post a reply